(Q46379587)

21 December 2017

title

Physiologically based pharmacokinetic modelling to predict single- and multiple-dose human pharmacokinetics of bitopertin (English)

1 reference

21 December 2017

1 reference

Neil Parrott

1

1 reference

21 December 2017

Dominik Hainzl

2

1 reference

21 December 2017

Daniela Alberati

3

1 reference

21 December 2017

Carsten Hofmann

4

1 reference

21 December 2017

Richard Robson

5

1 reference

21 December 2017

Bruno Boutouyrie

6

1 reference

21 December 2017

Meret Martin-Facklam

7

1 reference

21 December 2017

publication date

1 August 2013

1 reference

21 December 2017

Clinical Pharmacokinetics

published in

1 reference

21 December 2017

volume

52

1 reference

21 December 2017

issue

8

1 reference

21 December 2017

page(s)

673-683

1 reference

21 December 2017

https://scigraph.springernature.com/pub.10.1007/s40262-013-0061-x

exact match

0 references

cites work

A glimmer of light for neuropsychiatric disorders.

1 reference

https://api.crossref.org/works/10.1007%2FS40262-013-0061-X

Schizophrenia, "just the facts" 4. Clinical features and conceptualization

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40262-013-0061-X

Pharmacological treatment of schizophrenia: a critical review of the pharmacology and clinical effects of current and future therapeutic agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40262-013-0061-X

Glutamate and schizophrenia: phencyclidine, N-methyl-D-aspartate receptors, and dopamine-glutamate interactions

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40262-013-0061-X

Selective GlyT1 inhibitors: discovery of [4-(3-fluoro-5-trifluoromethylpyridin-2-yl)piperazin-1-yl][5-methanesulfonyl-2-((S)-2,2,2-trifluoro-1-methylethoxy)phenyl]methanone (RG1678), a promising novel medicine to treat schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40262-013-0061-X

Glycine reuptake inhibitor RG1678: a pharmacologic characterization of an investigational agent for the treatment of schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40262-013-0061-X

Physiologically-based pharmacokinetics in drug development and regulatory science

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40262-013-0061-X

An evaluation of the utility of physiologically based models of pharmacokinetics in early drug discovery.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40262-013-0061-X

Prediction of drug disposition in infants and children by means of physiologically based pharmacokinetic (PBPK) modelling: theophylline and midazolam as model drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40262-013-0061-X

Development of a physiologically based model for oseltamivir and simulation of pharmacokinetics in neonates and infants

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40262-013-0061-X

Physiology-based simulations of a pathological condition: prediction of pharmacokinetics in patients with liver cirrhosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40262-013-0061-X

Modeling and predicting drug pharmacokinetics in patients with renal impairment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40262-013-0061-X

Prediction of in vivo drug clearance from in vitro data. II: potential inter-ethnic differences

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40262-013-0061-X

Sources of interindividual variability in IVIVE of clearance: an investigation into the prediction of benzodiazepine clearance using a mechanistic population-based pharmacokinetic model.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40262-013-0061-X

Advances in screening for membrane permeability: high-resolution PAMPA for medicinal chemists

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40262-013-0061-X

Development of a 7-day, 96-well Caco-2 permeability assay with high-throughput direct UV compound analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40262-013-0061-X

Applications of physiologically based absorption models in drug discovery and development.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40262-013-0061-X

Prediction of pharmacokinetics prior to in vivo studies. II. Generic physiologically based pharmacokinetic models of drug disposition

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40262-013-0061-X

Prediction of hepatic metabolic clearance: comparison and assessment of prediction models

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40262-013-0061-X

A priori prediction of tissue:plasma partition coefficients of drugs to facilitate the use of physiologically-based pharmacokinetic models in drug discovery.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40262-013-0061-X

Predicting the impact of physiological and biochemical processes on oral drug bioavailability

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40262-013-0061-X

Dissolution testing as a prognostic tool for oral drug absorption: immediate release dosage forms

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40262-013-0061-X

Prediction of pharmacokinetics prior to in vivo studies. 1. Mechanism-based prediction of volume of distribution.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40262-013-0061-X

Predicting pharmacokinetic food effects using biorelevant solubility media and physiologically based modelling.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40262-013-0061-X

Medicinal chemical properties of successful central nervous system drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40262-013-0061-X

Volume of distribution at steady state for a linear pharmacokinetic system with peripheral elimination

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40262-013-0061-X

Physiologically based pharmacokinetic modelling 2: predicting the tissue distribution of acids, very weak bases, neutrals and zwitterions.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40262-013-0061-X

Prediction of intestinal absorption: comparative assessment of GASTROPLUS and IDEA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40262-013-0061-X

Role of physiological intestinal water in oral absorption

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40262-013-0061-X

Predicting pharmacokinetics of drugs using physiologically based modeling--application to food effects

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40262-013-0061-X

A framework for assessing inter-individual variability in pharmacokinetics using virtual human populations and integrating general knowledge of physical chemistry, biology, anatomy, physiology and genetics: A tale of 'bottom-up' vs 'top-down' recogn

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40262-013-0061-X

Application of PBPK modeling to predict human intestinal metabolism of CYP3A substrates - an evaluation and case study using GastroPlus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40262-013-0061-X

The prediction of drug metabolism, tissue distribution, and bioavailability of 50 structurally diverse compounds in rat using mechanism-based absorption, distribution, and metabolism prediction tools.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40262-013-0061-X

Simulation of human intravenous and oral pharmacokinetics of 21 diverse compounds using physiologically based pharmacokinetic modelling

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40262-013-0061-X

Mass spectrometry-based quantification of CYP enzymes to establish in vitro/in vivo scaling factors for intestinal and hepatic metabolism in beagle dog.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40262-013-0061-X

Simulation and prediction of in vivo drug metabolism in human populations from in vitro data

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40262-013-0061-X

Use of physiologically based pharmacokinetic modeling for assessment of drug-drug interactions.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40262-013-0061-X

Prediction of in vivo drug clearance from in vitro data. I: impact of inter-individual variability

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40262-013-0061-X

Prediction of the clearance of eleven drugs and associated variability in neonates, infants and children

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40262-013-0061-X

Pharmacologic treatment of first-episode schizophrenia: a review of the literature

21 January 2018

1 reference

12 December 2020

Physiological parameters in laboratory animals and humans

1 reference

12 December 2020

Evaluation of the effects of bitopertin (RG1678) on cardiac repolarization: a thorough corrected QT study in healthy male volunteers

1 reference

12 December 2020

Glycine transport inhibitors for the treatment of schizophrenia: symptom and disease modification

1 reference

12 December 2020

A novel strategy for physiologically based predictions of human pharmacokinetics

1 reference

12 December 2020

Best practice in the use of physiologically based pharmacokinetic modeling and simulation to address clinical pharmacology regulatory questions

1 reference

12 December 2020

Evaluation of various dissolution media for predicting in vivo performance of class I and II drugs

1 reference

12 December 2020

Application of full physiological models for pharmaceutical drug candidate selection and extrapolation of pharmacokinetics to man

1 reference

12 December 2020

10.1007/S40262-013-0061-X

Identifiers

DOI

1 reference

21 December 2017

PubMed ID

23591780

1 reference

21 December 2017